Business
Illinois drug maker AbbVie Inc. said Friday it would buy European rival Shire for $55 billion and reincorporate in Britain, allowing the company to slash its tax rate in the latest move by an American firm to shelter its foreign earnings.
July 18, 2014
Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world’s most tenacious diseases.
Nov. 16, 2014
Fluor Daniel said Thursday that it has won a $40-million contract in the large and growing biopharmaceuticals market.
Sept. 18, 1992
Science & Medicine
Tests of an experimental Ebola vaccine have shown positive results, protecting healthy monkeys from contracting the virus, the National Institutes of Health announced Sunday, as West Africa grapples with the epidemic that has killed around 2,000.
Sept. 7, 2014
CoCensys Inc.: The Irvine biopharmaceutical company reported a net loss of $6.1 million, or 27 cents a share, for the first quarter, compared with a net loss of $5.6 million, or 26 cents a share, for the comparable period last year.
May 15, 1997
CoCensys Inc.: The Irvine bio-pharmaceuticals company has named Lowell E.
June 15, 1995
Technology and the Internet
Vestar Inc., a bio-pharmaceutical company based in San Dimas, said it has been awarded a U.S. patent covering a manufacturing process for the large-scale production of liposomes . . .
June 29, 1988
CoCensys Inc.: The Irvine biopharmaceutical company said Tuesday that it is collaborating with Warner-Lambert Co. and its Parke-Davis division to develop and market drugs to treat central nervous system disorders.
Nov. 1, 1995
Opinion L.A.
This article was originally on a blog post platform and may be missing photos, graphics or links.
Sept. 14, 2011
CoCensys, Inc.: The Irvine biopharmaceutical company said it lost $5.8 million, or 36 cents a share, in the second quarter, compared to a loss of $16.1 million, or $1.70 a share, in the same period last year.
Aug. 3, 1995